278 related articles for article (PubMed ID: 32583968)
21. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19.
Zaami S; Piergentili R; Marinelli E; Montanari Vergallo G
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1752-1761. PubMed ID: 33629345
[TBL] [Abstract][Full Text] [Related]
22. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
Waryah CB; Moses C; Arooj M; Blancafort P
Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
24. Photoactivatable CRISPR-Cas9 for optogenetic genome editing.
Nihongaki Y; Kawano F; Nakajima T; Sato M
Nat Biotechnol; 2015 Jul; 33(7):755-60. PubMed ID: 26076431
[TBL] [Abstract][Full Text] [Related]
25. Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants.
Monsur MB; Shao G; Lv Y; Ahmad S; Wei X; Hu P; Tang S
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344599
[TBL] [Abstract][Full Text] [Related]
26. The Basis and Promise of Programmable RNA Editing and Modification.
Lo N; Xu X; Soares F; He HH
Front Genet; 2022; 13():834413. PubMed ID: 35154288
[TBL] [Abstract][Full Text] [Related]
27. [Manipulating Living Systems by Light].
Sato M
Yakugaku Zasshi; 2020; 140(8):993-1000. PubMed ID: 32741873
[TBL] [Abstract][Full Text] [Related]
28. Optogenetic regulation of embryo implantation in mice using photoactivatable CRISPR-Cas9.
Takao T; Sato M; Maruyama T
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28579-28581. PubMed ID: 33139551
[TBL] [Abstract][Full Text] [Related]
29. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
30. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
Newsom S; Parameshwaran HP; Martin L; Rajan R
Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
Manghwar H; Lindsey K; Zhang X; Jin S
Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
[TBL] [Abstract][Full Text] [Related]
32. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
[No Abstract] [Full Text] [Related]
35. RNA-Targeting CRISPR-Cas Systems and Their Applications.
Burmistrz M; Krakowski K; Krawczyk-Balska A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
[TBL] [Abstract][Full Text] [Related]
36. [Recent progresses in CRISPR genome editing in plants].
Li H; Xie K
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
[TBL] [Abstract][Full Text] [Related]
38. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
40. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
Chen X; Chen Y; Xin H; Wan T; Ping Y
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]